| Anaplastic (Malignant) Meningioma studied in …STUDIED_INderived15 of 15show fewer |
|---|
| → studied in | NCT02847559Phase 2 · completed Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma · condition mapped ONTOLOGY_EXACT · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04541082Phase 1 · recruiting Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05793034NA · recruiting Predictive Factors for Survival in Aggressive Meningiomas · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016091Phase 2 · terminated A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03434262Phase 1 · completed SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019578Phase 1 · completed Stereotactic Radiosurgery in Treating Patients With Brain Tumors · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02973256unknown Oncological Care for Patients With Meningioma · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01125046Phase 2 · completed Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234805NA · terminated Yoga Therapy in Treating Patients With Malignant Brain Tumors · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02194452NA · withdrawn Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02967380NA · terminated Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases · condition mapped ONTOLOGY_EXACT · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119599Phase 1 · completed RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma · condition mapped ONTOLOGY_EXACT · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082926Phase 1 · completed Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492089Phase 2 · completed Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003292Phase 2 · terminated S9624 Ifosfamide in Treating Patients With Meningeal Tumors · condition mapped ALIAS · 15 trials mapped (2 active) | — | — | Adult Anaplastic (Malignant) Meningioma | 1 | Observed | clinicaltrials | graph → |